Basic Information
Basic information for PART1-204-41aa-3
Peptide Name PART1-204-41aa-3
Genome Position chr5:60523483-60523605[+]
Species Human
Peptide Sequence MLSCIFSPILPDILKGAVQLQHSLHTQLYHLSTLYLALTYT
Peptide Length 41
Unique No (PART1-201-41aa-3)
Grand Average of Hydropathicity 0.622
Relative Molecular Mass 5365.22
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000152931;PART1
Transcript ID/Name ENST00000661844;PART1-204
Transcript Length 6029
Coding Ability 0.4301
DNA Sequence Corresponding to Peptide ATGCTATCCTGCATTTTCTCTCCAATCTTACCTGACATCTTGAAGGGAGCAGTTCAGTTACAGCATTCTCTCCATACCCAACTATACCATCTCTCTACTCTTTATCTTGCCCTCACATACACA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :